Online Education | Neuropsychotropic Drug Therapy 2019
This online lecture series is designed as a neuropsychotropic pharmacology update at the advanced practice level. Sessions focus on current recommendations and controversies in drug therapy for common neuropsychiatric health concerns. Teaching methods include lecture, discussion and case analysis.
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
Upon completion of this conference, participants will be better able to:
- Describe the role and optimize the use of medications in PTSD treatment in your setting.
- Recognize the diagnostic criteria for eating disorders, including: anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant restrictive food intake disorder.
- Apply basic understanding of drug-induced movement disorders.
- Recognize migraines quickly in clinic.
- Discuss ketamine pharmacology.
|Psychological Trauma, PTSD and Pain: The Role and Risks of Medications||Stephen Hunt, MD|
|Eating Disorders and the Role of Psychopharmacology||Sarah Golub, MD, MPH|
|Drug-Induced Movement Disorders: Managing Drug-Induced Tremors and Tardive Dyskinesia||Kimmy Su, MD, PhD|
|CGRP Agents for Migraine Prevention||Donald Bright, MD|
|Ketamine Assisted Psychtherapy for Psychiatric Disorders||Nathaniel Schmidt, DNP, ARNP, PMHNP-BC|
Donald Bright, MD
Staff Neurologist, VA Puget Sound Health Care System, Seattle
Sarah Golub, MD, MPH
Stephen Hunt, MD
Director, Deployment Health Clinic, VA Puget Sound Health Care System, Seattle
Nathaniel Schmidt, DNP, ARNP, PMHNP-BC
Nurse Practitioner, Private Practice, Advanced Integrative Medical Science Institute, Seattle
Kimmy Su, MD
Fellow, Movement Disorders, VA Puget Sound Health Care System, Seattle
- 5.70 Contact hours
- 5.70 Pharmacology hours at the advanced practice level
For registration assistance, please contact the Registration Manager at 206-543-1047 or email@example.com.